2019

• das Nair, R., Topcu, G., Evangelou, N., Drummond, A., Fitzsimmons, D., Croft, A., Kendrick, D., Martin, J., Moore, P., Leighton, P., Thomas, S., Timmons, S., Vernon, K., & Hoare, Z. (2019). Neuropsychological Evaluation and Rehabilitation in Multiple Sclerosis - Developing, evaluating and implementing a clinical management pathway (NEuRoMS). NIHR Programme Grant for Applied Research, £1,852,239.
• Evangelou, N., Allen, C., Dineen, R., Fitzsimmons, D., Craner, M., Tallantyre, E., Schmierer, K., das Nair, R. Morgan, P., Partlett, C., & Bale, C. (2019). Diagnose using the Central Vein Sign: A prospective diagnostic superiority study comparing T2* MRI and lumbar puncture in patients presenting with possible multiple sclerosis. NIHR Research for Patient Benefit. £349,461. (07.2019 – 07.2022)
• Tanasescu, R., Evangelou, N., das Nair, R., Auer, D., Garibaldi, J., Ontaneda, D. (2019). AI gets real: using routine clinical data and Artificial Intelligence to predict worsening of Multiple Sclerosis despite treatment (AIMS). MRC - NIHR Clinical Academic Research Partnerships. £249,361
• Dineen, R., et al. (2019). A Feasibility Trial of Neuromodulation with Connectivity-Guided Intermittent Theta Burst Stimulation for Cognitive Impairment in MS. MS Society. £244,826
• das Nair, R., Evangelou, N., Mhizha-Murira, J., & Moghaddam, N. (2019). Determining who benefits most from cognitive rehabilitation. MS Society, PhD studentship. £77,900 (02.2020 – 01.2023)
• das Nair, R. & Topcu, G. (2019). Building a multiple sclerosis patient and public involvement community for people with multiple sclerosis in Nottinghamshire. Public Engagement Small Grant. Institute for Policy & Engagement. £3,500.

 2018

• das Nair, R. & Radford, K. (2018). Preventing job loss in people with multiple sclerosis. Joan Browne Legacy Funding, £75,000

 2017

• Dineen, R., Sotiropoulos, S., Auer, D., Morgan, P., Evangelou, N., Constantinescu, C., das Nair, R. (2017). Explaining cognitive impairment in multiple sclerosis through integrated structural and functional networks. Medical Research Council, £97,316.
• Ontaneda D & Evangelou N. (2017). Determining the Effectiveness of Early Intensive versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis (DELIVER-MS), PCORI, $10,630,672.
• Evangelou, N. & das Nair, R. (2017). Developing and evaluating psychological interventions for support around the time of multiple sclerosis diagnosis. John Mortimer Shipstone Ratcliff Medical Scholarship, £57,832.
• das Nair, R., Topcu, G., Evangelou, N., Drummond, A., Bale, C., Fitzsimmons, D., Vernon, K., & Rose, A. (2017). Intervention to support individuals around the point of multiple sclerosis diagnosis. MS Society, £172,251.

 2016

• Tanasescu, R., Constantinescu CS. (2016). Interactive effects of Teriflunomide, Simvastatin and Lisinopril on transporter proteins and cytokine expression in cultured primary human brain microvascular endothelium. Genzyme Pharma. £93,960
• Dineen, R. A., Lincoln, N., das Nair, R., and Constantinescu, C. S. (2016). MRI markers predictive of treatment response to cognitive rehabilitation in the CRAMMS trial.           MS Research, £24,739
• Hotopf M, Stewart R, Wykes T, Richardson M, Hollis C, Morriss R, Craven M and 23 other partners (2016-2020). RADAR-CNS. Remote assessment of disease and relapse in central nervous system disorders. EU Horizon 2020, €14,000,000.

 2015

• Drummond, A., das Nair, R., Thomas, S. (2015). Implementing cognitive rehabilitation for people with MS: Translating research into clinical practice. MS Society PhD Studentship Grant, £64,665.
• Gran, B. (2015). Role of innate immunity in neuroinflammation. MS International Federation (supervisor to MSIF MacDonald Fellow). £64,000.

 2014

• Drummond, A. & das Nair, R. (2014). Delivering cognitive rehabilitation to people with Multiple Sclerosis. MS Society PhD Studentship. £67,468.
• Gran, B. (2014). How do infections activate inflammation in MS? Role of TLR2. Italian MS Society. €126,550.
• Lincoln, N.B. (Co-CI), das Nair, R. (Co-CI), Drummond, A., Constantinescu, C., Montgomery, A., Morgan, M., & Phillips, C. (2014). Cognitive Rehabilitation of Attention and Memory for people with Multiple Sclerosis: A pragmatic randomised controlled trial. National Institute of Health Research – Health Technology Assessment. £1,167,000 (4 years).

 2013

• Dineen, R. A., Constantinescu, C. S. and Auer, D. P. (2013).  Brain Network Dysfunction in Multiple Sclerosis. MS Society PhD studentship. £95,794

 2012

• Edwards LJ. Constantinescu CS. - Assessment of central and peripheral regulation of inflammation in multiple sclerosis. Anne McLaren Research Fellowship. £58,416.
• Gran, B. (2012). Toll-like receptors modulate the balance between Treg and Th17 cells: Implications for multiple sclerosis. Italian MS Society. €28,000.
• Lincoln, N.B., & das Nair, R. (2012). Understanding how group-based interventions work: a social identity approach to adjustment groups for people with multiple sclerosis. MS Society Studentship. £65,669 (3 years).
• Lincoln, N.B., das Nair, R., Hunt, N., & Smale, K. (2012). The contribution of identity processes to psychological adjustment in multiple sclerosis. ESRC studentship. £55,000 (3 years).
• Lincoln, N.B, das Nair, R. & Bateman, A. (2012). Evaluation of Neuropage as a memory aid for people with multiple sclerosis. MS Society PhD Studentship. £73,245 (3 years).
• das Nair, R. (CI) & Lincoln, N. (2012). Comparing individual vs. group psychological adjustment interventions for people with multiple sclerosis: A pilot randomised controlled trial. Pump-priming Competition 2012, Nottingham University Hospitals Charity and R&I. £10,992 (6 months).
• Constantinescu CS, Pritchard DI, Auer DP, Tench RT, Tanasescu RI, et al. WIRMS (Worms for Immune regulation in MS); MS Society £400,000.
• Constantinescu CS, Jones RDE, Bath PM, et al. MSC-MSC (Mesenchymal Stem Cells in MS and Controls); MS Society, £60,000
• Constantinescu CS, et al. MOR-103 in relapsing MS. Morphosys: clinical trial and ancillary immunology study, ~£100,000
• Tanasescu RI, Constantinescu CS, Teriflunomide, simvastatin and lisinopril: effects at the blood brain barrier, Sanofi, ~£100,000.
• Constantinescu CS, Pritchard DI: GM-CSF, EBV, and hookworm in MS. Forman Hardy Charitable Trust, £50,000.

 2010

• Edwards LJ. Biomarkers in multiple sclerosis. MS Society / Fulbright Research Award, £75,000.

 2008

• Lincoln, N.B., Constantinescu, C., Drummond, A., Armstrong, S., & Phillips, C. (2008). Psychological Treatment for people with Multiple Sclerosis and Low Mood. MS Society. £130,769.

 2007

• Edwards LJ., Constantinescu CS - Th17 cells in Multiple Sclerosis - Patrick Berthoud Research Fellowship. £163,214.
• Edwards LJ, Constantinescu CS – Tetanus vaccination in multiple sclerosis – Mason Medical Research Foundation. £9,500.